Suppr超能文献

术前能否预测晚期上皮性卵巢癌的初次最佳肿瘤细胞减灭术?

Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?

机构信息

Department of Gynecology Oncology, vali-e-asr hospital, Tehran University of Medical Sciences, Keshavarz Blvd, Tehran, 1419733141, Iran.

出版信息

World J Surg Oncol. 2010 Feb 19;8:11. doi: 10.1186/1477-7819-8-11.

Abstract

INTRODUCTION

Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively.

METHODS

Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan. to June 2008 at gynecologic oncology ward of TUMS (Tehran University of Medical Sciences) were eligible for this study. The possibility of predicting primary optimal cytoreduction considering multiple variables was evaluated. Variables were peritoneal carcinomatosis, serum CA125, ascites, pleural effusion, physical status and imaging findings.Univariate comparisons of patients underwent suboptimal cytoreduction carried out using Fisher's exact test for each of the potential predictors. The wilcoxon rank sum test was used to compare variables between patients with optimal versus suboptimal cytoreduction.

RESULTS

41 patients met study inclusion criteria. Statistically significant association was noted between peritoneal carcinomatosis and suboptimal cytoreduction. There were no statistically significant differences between physical status, pleural effusion, imaging findings, serum CA125 and ascites of individuals with optimal cytoreduction compared to those with suboptimal cytoreduction.

CONCLUSIONS

Because of small populations in our study the results are not reproducible in alternate populations. Only the patient who is most unlikely to undergo optimal cytoreduction should be offered neoadjuvant chemotherapy, unless her medical condition renders her unsuitable for primary surgery.

摘要

介绍

预测术前晚期上皮性卵巢癌患者的最佳肿瘤细胞减灭术。

方法

本研究纳入了 2008 年 1 月至 6 月在 TUMS(德黑兰医科大学)妇科肿瘤科首次接受手术的晚期上皮性卵巢癌患者。评估了考虑多种变量预测初次最佳肿瘤细胞减灭术的可能性。变量包括腹膜癌病、血清 CA125、腹水、胸腔积液、身体状况和影像学表现。对于每个潜在的预测因子,使用 Fisher 确切检验对行次优肿瘤细胞减灭术的患者进行单变量比较。Wilcoxon 秩和检验用于比较最佳肿瘤细胞减灭术和次优肿瘤细胞减灭术患者之间的变量。

结果

41 例患者符合研究纳入标准。腹膜癌病与次优肿瘤细胞减灭术之间存在统计学显著关联。与行最佳肿瘤细胞减灭术的患者相比,行次优肿瘤细胞减灭术的患者在身体状况、胸腔积液、影像学表现、血清 CA125 和腹水方面无统计学差异。

结论

由于本研究的患者人群较小,因此研究结果在其他人群中不可复制。只有最不可能行最佳肿瘤细胞减灭术的患者才应接受新辅助化疗,除非她的身体状况不适合行初次手术。

相似文献

3
Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer.上皮性卵巢癌最佳肿瘤细胞减灭术预测模型
Asian Pac J Cancer Prev. 2018 May 26;19(5):1319-1324. doi: 10.22034/APJCP.2018.19.5.1319.

本文引用的文献

4
Predictive factors for irresectability in advanced ovarian cancer.晚期卵巢癌不可切除性的预测因素。
Int J Gynecol Cancer. 2004 May-Jun;14(3):423-30. doi: 10.1111/j.1048-891x.2004.014301.x.
8
Cancer statistics, 2003.2003年癌症统计数据。
CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26. doi: 10.3322/canjclin.53.1.5.
10
Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma.
Int J Gynecol Cancer. 2001 Nov-Dec;11(6):466-70. doi: 10.1046/j.1525-1438.2001.01064.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验